Seventure et al. back EndoControl

Ellie Pullen
10 December 2013

Tweet
Facebook
LinkedIn
Google plus
Send to

Seventure Partners, CM-CIC Capital Innovation and Viveris Management have injected €4m into EndoControl, a French surgical robotics developer.

The funding from the series-C round will allow EndoControl to finance its research and development activities for new equipment and bolster the company's market position on an international scale, with a focus on Asia and the Middle East.

Previous funding
CM-CIC (then Vizille Capital Innovation) and Sudinnova invested €1.05m in EndoControl's series-A round in June 2007.

In March 2010, new backer Seventure led a €3m series-B round for the company alongside previous investors Vizille and Sudinnova.

Company
Founded in 2006, EndoControl is headquartered in Grenoble with a US office in Dover, Delaware. The company develops robotic assistance systems for use in endoscopic surgery.

EndoControl's ViKY product, which gained CE marking and FDA clearance in 2007 and 2008 respectively, is a robotic assistant for minimally invasive surgery, also known as laparoscopy or keyhole surgery. The ViKY EP is a motorised endoscope holder, while the ViKY UP is a motorised uterus positioner.

The company's JAiMY product received CE marking in 2011. It is a 5mm motorised instrument designed to recreate a surgeon's hand movements for the purpose of performing complex surgeries through tiny skin incisions.

People
Clement Vidal is the CEO of EndoControl and founded the business alongside vice president Patrick Henri. Karine Lignel is an investment director at CM-CIC, while Philippe Reynaud is an investment director at Viveris.